Application of 14N NQR to the study of piroxicam polymorphism

Journal of Pharmaceutical Sciences

Volumn 99, Issue 12, 2010, Pages 4857-4865

  Lavrič, Zoran ^a   Pirnat, Janez ^b   Lužnik, Janko ^b   Seliger, Janez ^c   ŽAgar, Veselko ^c   Trontelj, Zvonko ^b   Srčič, Stane ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b INSTITUTE OF MATHEMATICS   (Slovenia)

^c JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

Calorimetry (DSC); FT IR; Physical characterization; Piroxicam; Polymorphism; Powder mixture quantification; Relaxation time; Solid state NMR; Spectroscopy

Indexed keywords

1,2 DICHLOROETHANE; ALCOHOL; NITROGEN; PIROXICAM; EXCIPIENT; SOLVENT;

ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG STRUCTURE; INFRARED SPECTROSCOPY; NITROGEN NUCLEAR MAGNETIC RESONANCE; NUCLEAR QUADRUPOLE RESONANCE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SIGNAL NOISE RATIO; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; EVALUATION; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; QUANTUM THEORY; RADIOFREQUENCY RADIATION; SPECTROSCOPY; TEMPERATURE; VIBRATION;

CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; ETHANOL; ETHYLENE DICHLORIDES; EXCIPIENTS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; NITROGEN; PIROXICAM; QUANTUM THEORY; RADIO WAVES; SOLVENTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SPECTRUM ANALYSIS; TEMPERATURE; VIBRATION;

EID: 77957905995     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22186     Document Type: Article

References (41)

1. Brittain HG, editor. 1999. Polymorphism in pharmaceutical solids. Drugs and the pharmaceutical sciences, series 95. New York: Marcel Dekker.
2. Singhal D, Curatolo W. 2004. Drug polymorphism and dosage form design: A practical perspective. Adv Drug Deliv Rev 56: 335-347.
3. Brittain HG. 2008. Polymorphism and Solvatomorphism 2006. J Pharm Sci 97: 3611-3636.
4. British Pharmacopoeia Commission. 2006. British Pharmacopoeia 2007. London: The Stationery Office.
5. Kunaver M, Zadnik J, Planinšek O, Srčič S. 2004. Inverse gas chromatography-A different approach to characterization of solids and liquids. Acta Chim Slov 51: 373-394.
6. Findlay WP, Bugay DE. 1998. Utilization of Fourier transform-Raman spectroscopy for the study of pharmaceutical crystal forms. J Pharm Biomed Anal 16: 921-930.
7. Xie Y, Tao W, Morrison H, Chiu R, Jona J, Fang J, Cauchon N. 2008. Quantitative determination of solid-state forms of a pharmaceutical development compound in drug substance and tablets. Int J Pharm 362: 29-36.
8. Skorda D, Kontoyannis CG. 2008. Identification and quantitative determination of atorvastatin calcium polymorph in tablets using FT-Raman spectroscopy. Talanta 74: 1066-1070.
9. Li W, Worosila GD, Wang W, Mascaro T. 2005. Determination of polymorph conversion of an active pharmaceutical ingredient in wet granulation using NIR calibration models generated from the premix blends. J Pharm Sci 94: 2800-2806.
10. Helmy R, Zhou GX, Chen YW, Crocker L, Wang T, Wenslow RM, Vailaya A. 2003. Characterization and quantitation of aprepitant drug substance polymorphs by attenuated total reflectance Fourier transform infrared spectroscopy. Anal Chem 75: 605-611.
11. Blanco M, Valdes D, Bayod MS, Fernandez-Mari F, Llorente I. 2004. Characterization and analysis of polymorphs by near-infrared spectrometry. Anal Chim Acta 502: 221-227.
12. Patel AD, Luner PE, Kemper MS. 2001. Low-level determination of polymorph composition in physical mixtures by near-infrared reflectance spectroscopy. J Pharm Sci 90: 360-370.
13. Taday PF. 2004. Applications of terahertz spectroscopy to pharmaceutical sciences. Phil Trans R Soc Lond A 362: 351-364.
14. Lu Q-L, Yang G, Gu H. 2005. Phase quantification of two chlorothalonil polymorphs by X-ray powder diffraction. Anal Chim Acta 538: 291-296.
15. Cao W, Bates S, Peck GE, Wildfong PLD, Qiu Z, Morris KR. 2002. Quantitative determination of polymorphic composition in intact compacts by parallel-beam X-ray powder diffractometry. J Pharm Biomed Anal 30: 1111-1119.
16. Wildfong PLD, Morley NA, Moore MD, Morris KR. 2005. Quantitative determination of polymorphic composition in intact compacts by parallel-beam X-ray powder diffractometry II Data correction for analysis of phase transformations as a function of pressure. J Pharm Biomed Anal 39: 1-7.
17. Berendt RT, Sperger DM, Isbester PK, Munson EJ. 2006. Solid-state NMR spectroscopy in pharmaceutical research and analysis. Trends Anal Chem 25: 977-984.
18. Saindon PJ, Cauchon NS, Sutton PA, Chang C-J, Peck GE, Byrn SR. 1993. Solid-state nuclear magnetic resonance (NMR) spectra of pharmaceutical dosage forms. Pharm Res 10: 197-203.
19. Griffin JM, Martin DR, Brown SP. 2007. Distinguishing anhydrous and hydrous forms of an active pharmaceutical ingredient in a tablet formulation using solid-state NMR spectroscopy. Angew Chem Int Ed 46: 8036-8038.
20. Latosinska JN. 2005. Nuclear quadrupole resonance spectroscopy in studies of biologically active molecular systems-A review. J Pharm Biomed Anal 38: 577-587.
21. Osan TM, Cerioni LMC, Forguez J, Olle JM, Pusiol DJ. 2007. NQR: From imaging to explosives and drug detection. Phys B 389: 45-50.
22. Das TP, Hahn EL. 1958. Nuclear quadrupole resonance spectroscopy. Solid state physics advances in research and applications, supplement 1. New York: Academic Press.
23. Lucken EAC. 1969. Nuclear quadrupole coupling constants. London: Academic Press.
24. Chihara H, editor. 1997. Nuclear quadrupole resonance spectroscopy data III/39. Landolt-Bornstein numerical data and functional relationships in science and technology-New series. Springer-Verlag, Berlin, Heidelberg: Springer.
25. Perez SC, Cerioni L, Wolfenson AE, Faudone S, Cuffini SL. 2005. Utilization of pure nuclear quadrupole resonance spectroscopy for the study of pharmaceutical crystal forms. Int J Pharm 298: 143-152.
26. Marino RA, Klainer SM. 1977. Multiple spin echoes in pure quadrupole resonance. J Chem Phys 67: 3388-3389.
27. Rudakov TN, Mikhaltsevich VT, Selchikhin OP. 1997. The use of multi-pulse nuclear quadrupole resonance techniques for the detection of explosives containing RDX. J Phys D: Appl Phys 30: 1377-1382.
28. Carr HY, Purcell EM. 1954. Effects of diffusion on free precession in nuclear magnetic resonance experiments. Phys Rev 94: 630-638.
29. Meiboom S, Gill D. 1958. Modified spin-echo method for measuring nuclear relaxation times. Rev Sci Instrum 29: 688-691.
30. Levitt MH. 2008. Spin dynamics: Basics of nuclear magnetic resonance, 2nd edition. Chichester: John Wiley & Sons.
31. Blumich B, Perlo J, Casanova F. 2008. Mobile single-sided NMR. Prog Nucl Mag Res Spectrosc 52: 197-269.
32. Suwelack D, Waugh JS. 1980. Quasistationary magnetization in pulsed spin-locking experiments in dipolar solids. Phys Rev B 22: 5110-5114.
33. 35Cl in cocaine base and hydrochloride using NQR, NMR, and SQUID techniques. Anal Chem 67: 2256-2263.
34. Rudakov TN, Mikhaltsevich VT. 2003. Multiple NQR spin echoes in phase cycled pulse experiments. Phys Lett A 309: 465-469.
35. Rudakov TN. 2007. Some aspects of spin-locking effect in nitrogen-14 quadrupolar spin-system. Chem Phys Lett 443: 269-273.
36. 14N nuclei. J Appl Phys 102: 084903.1-084903.7.
37. Vrečer F, Vrbinc M, Meden A. 2003. Characterization of piroxicam crystal modifications. Int J Pharm 256: 3-15.
38. 14N nuclear quadrupole resonance of picolinic, nicotinic, isonicotinic and dinicotinic acids. Chem Phys 331: 131-136.
39. 14N nuclear quadrupole resonance of some sulfa drugs. Solid State Nucl Magn Reson 30: 61-68.
40. 14N NQR study of nicotinamide and related compounds. Magn Reson Chem 46: 58-62.
41. Wolfram S. 3D Multipole Shapes. (accessed 18/9/09), part of The Wolfram Demonstrations Project. (accessed 18/9/09).